ENTEROVAX RES PTY LTD has a total of 20 patent applications. Its first patent ever was published in 1985. It filed its patents most often in Australia, Denmark and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, pharmaceuticals and environmental technology are MEDEVA HOLDINGS BV, GUANGZHOU CAS LAMVAC BIOTECH CO LTD and HEBEI YILING MEDICINE INST CO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | Denmark | 5 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | Japan | 3 | |
#5 | Italy | 1 | |
#6 | WIPO (World Intellectual Property Organization) | 1 | |
#7 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Environmental technology | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Microorganisms | |
#4 | Climate change adaptation technologies | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Manning Paul A | 8 |
#2 | Morona Renato | 6 |
#3 | Rowley Derrick | 6 |
#4 | Reeves Peter R | 5 |
#5 | Hackett James Anthony | 3 |
#6 | Renaato Morona | 2 |
#7 | Hone David Michael | 2 |
#8 | Jieemusu Ansonii Haketsuto | 1 |
#9 | Manning Paul A Dr | 1 |
#10 | Rowley Professor Derrick | 1 |
Publication | Filing date | Title |
---|---|---|
AU4298089A | Bacterial strains | |
DK433189D0 | Hybrid bactery stems | |
EP0257837A1 | Hybrid bacterial strain | |
EP0251579A2 | Non-antibiotic marker system | |
AU7420287A | Non-antibiotic marker system | |
DK294987D0 | Plasmid, called pade161, its manufacturing and use | |
EP0249449A1 | Bacterial strain for live vaccines | |
AU7384387A | Avirulent bacterial strains used in live vaccine preparation | |
EP0175699A1 | Bacterial strains. | |
ZA8500749B | Bacterial strains |